These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8733827

  • 1. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
    Imagawa A, Itoh N, Hanafusa T, Katsura H, Yamaguchi A, Takeda A, Iwahashi H, Nakajima H, Miyagawa J, Namba M, Kuwajima M, Matsuzawa Y.
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Yamaguchi Y, Akazawa S, Nagataki S.
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N, Takino H, Yano M, Kawasaki E, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S.
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [Abstract] [Full Text] [Related]

  • 4. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
    Yang L, Zhou ZG, Huang G, Yan X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M, Moriuchi R, Kawasaki E, Watanabe M, Saito K, Takino H, Akazawa S, Miyamoto T, Nagataki S.
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [Abstract] [Full Text] [Related]

  • 6. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
    Maugendre D, Sonnet E, Derrien C, Le Golff MC, Grais MC, Allannic H, Delamaire M.
    Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
    [Abstract] [Full Text] [Related]

  • 7. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG.
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W.
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC, Levy-Marchal C.
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 11. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ, French MB, Chosich N, Harrison LC.
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [Abstract] [Full Text] [Related]

  • 12. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
    Maugendre D, Chaillous L, Rohmer V, Lecomte P, Marechaud R, Saï P, Marre M, Charbonnel B, Allannic H, Delamaire M.
    Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
    [Abstract] [Full Text] [Related]

  • 13. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.
    Orv Hetil; 1999 Nov 28; 140(48):2695-701. PubMed ID: 10645715
    [Abstract] [Full Text] [Related]

  • 14. [Islet cell antibodies].
    Hanafusa T.
    Rinsho Byori; 1995 May 28; 43(5):460-2. PubMed ID: 7783363
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
    Elkadhi A, Khelifi N, Abid A, Nagati K, Jenhani F, Ben Rayana MC.
    Tunis Med; 2002 May 28; 80(5):281-5. PubMed ID: 12534034
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
    Schmidli RS, DeAizpurua HJ, Harrison LC, Colman PG.
    J Autoimmun; 1994 Feb 28; 7(1):55-66. PubMed ID: 8198702
    [Abstract] [Full Text] [Related]

  • 17. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B, Zimmy S, Schatz H, Pfohl M.
    Med Klin (Munich); 2003 Feb 15; 98(2):67-71. PubMed ID: 12601530
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA.
    J Clin Invest; 1993 May 15; 91(5):2084-90. PubMed ID: 8486775
    [Abstract] [Full Text] [Related]

  • 19. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R, Verge CF, Moromisato-Gianani RI, Yu L, Zhang YJ, Pugliese A, Eisenbarth GS.
    J Autoimmun; 1996 Jun 15; 9(3):423-5. PubMed ID: 8816981
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y.
    Exp Clin Endocrinol Diabetes; 1997 Jun 15; 105(6):327-30. PubMed ID: 9439927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.